Chemoinformaics analysis of ETHYL N-(O-ANISYL)FORMIMIDATE
Molecular Weight | 179.219 | nRot | 4 |
Heavy Atom Molecular Weight | 166.115 | nRig | 7 |
Exact Molecular Weight | 179.095 | nRing | 1 |
Solubility: LogS | -1.038 | nHRing | 0 |
Solubility: LogP | 2.452 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 28.0723 |
nHD | 0 | BPOL | 17.6537 |
QED | 0.525 |
Synth | 2.404 |
Natural Product Likeliness | -0.689 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.006 |
HIA | 0.003 |
CACO-2 | -4.625 |
MDCK | 0.0000284 |
BBB | 0.266 |
PPB | 0.174527 |
VDSS | 4.343 |
FU | 0.63003 |
CYP1A2-inh | 0.983 |
CYP1A2-sub | 0.929 |
CYP2c19-inh | 0.531 |
CYP2c19-sub | 0.897 |
CYP2c9-inh | 0.076 |
CYP2c9-sub | 0.792 |
CYP2d6-inh | 0.707 |
CYP2d6-sub | 0.914 |
CYP3a4-inh | 0.509 |
CYP3a4-sub | 0.659 |
CL | 7.192 |
T12 | 0.589 |
hERG | 0.01 |
Ames | 0.97 |
ROA | 0.041 |
SkinSen | 0.194 |
Carcinogencity | 0.971 |
EI | 0.873 |
Respiratory | 0.061 |
NR-Aromatase | 0.018 |
Antiviral | No |
Prediction | 0.867821 |